Clinical Trials Browser

Recruiting × Recurrence × Calcium Dobesilate × Clear all

NCT05519085 2026-05-27

SUCCESSOR-1

Phase 3 Recruiting

Multiple Myeloma, Recurrence

NCT05530421 2026-02-23

SELVEDge

Phase 2 Recruiting

Multiple Myeloma, Recurrence

NCT06518551 2025-12-11

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

Phase 1/2 Recruiting

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell